Source: BioPortfolio

Thar Pharmaceuticals: Thar Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 24022017 Prices from USD $250

SummaryThar Pharmaceuticals Inc Thar Pharma a subsidiary of Grunenthal GmbH is a healthcare solution provider that concentrates on transforming intravenous IV drugs into oral drugs for existing and new indications. The company's lead product T121 an oral f...

Read full article »
Thar Pharmaceuticals's Competitors | Thar Pharmaceuticals's News | Thar Pharmaceuticals's Financials
Stay up-to-date with the latest news on Thar Pharmaceuticals
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Raymond K. Houck's photo - President & CEO of Thar Pharmaceuticals

President & CEO

Raymond K. Houck

CEO Approval Rating

68/100

Read more
Stay up-to-date with the latest news on Thar Pharmaceuticals